… The newly discovered molecular features of well-differentiated thyroid carcinomas derived …
of thyroid tumours, under the following headings: “Follicular carcinoma”, “Papillary carcinoma”…

… be a promising oncogene to target for personalized therapy in thyroid carcinomas (34).
Another oncogenic event in thyroid carcinomas has emerged. Mutations in the promoter region of …

… molecular pathological techniques applicable to thyroid FNA. The molecular pathology of
thyroid tumours is … This review concentrates on the use of molecular methods for diagnosis and …

… Thyroid cancer is the most common endocrine malignancy. Knowledge of the molecular
pathology of thyroid tumours … Common molecular alterations, such as BRAF p.V600E, RAS point …

… In this review we summarize studies on the molecular biology of the differentiated thyroid
tumors, with particular interest in the associated genetic lesions and their role in thyroid …

… Advances in understanding the molecular mechanisms that lead to the development and …
We review the molecular alterations implicated in thyroid cancer initiation and progression, …

… Molecular genetic study comparing follicular variant versus classic papillary thyroid
carcinomas: Association of N-ras mutation in codon 61 with follicular variant. Hum Pathol 2006;37:…

… ongoing phase II trials of BAY 43-9006 (Sorafenib) in anaplastic thyroid carcinoma and
metastatic medullary thyroid carcinoma are yet to be released. It will be important to find whether …

… risk of thyroid cancer of approximately 10%. Loss of PTEN activity also plays a role in …
thyroid carcinomas. Intragenic PTEN mutations are rare, particularly in well-differentiated thyroid …

… other emerging molecular markers will likely improve the diagnosis of malignancy in thyroid
… follicular thyroid carcinoma and discuss the diagnostic and prognostic significance thereof. …